@misc{indiciaea11baedc9079,
  title = {Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model},
  author = {Bessiere, P. and Wasniewsk, M. and Picard-Meyer, E. and Servat, A. and Figueroa, T. and Foret-Lucas, C. and Coggon, A. and Lesellier, S. and Boue, F. and Cebron, N. and Gausseres, B. and Trumel, C. and Foucras, G. and Salguero, F. J. and Monchatre-Leroy, E. and Volmer, R.},
  year = {2021},
  doi = {10.1101/2021.02.09.430458},
  url = {https://www.biorxiv.org/content/10.1101/2021.02.09.430458v1},
  note = {Source identifier: 10.1101/2021.02.09.430458}
}